INR 2.01
(5.24%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | 1.44 Billion | 2.07 Billion | -1.93 Billion | 633.2 Million | 1.48 Billion |
Net Income | - | -6.97 Billion | -1.84 Billion | -57.31 Million | 615.3 Million | 902.42 Million |
Depreciation & Amortization | - | 1.36 Billion | 1.65 Billion | 1.66 Billion | 454.22 Million | 254.97 Million |
Deferred income taxes | - | -285.06 Million | 624.97 Million | -77.45 Million | -67.35 Million | -258.81 Million |
Stock-based compensation | - | -5.66 Million | -3.85 Million | 11.34 Million | 37.18 Million | 17.94 Million |
Change in working capital | - | 39.5 Million | 959.5 Million | -4.29 Billion | -559.76 Million | 520.04 Million |
Other non-cash items | - | 7.31 Billion | 680.98 Million | 822.21 Million | 153.62 Million | 49.17 Million |
Investing Cash Flow | - | 150.92 Million | 4.18 Million | -3.29 Billion | -1.82 Billion | -1.13 Billion |
Investments in PPE | - | -127.79 Million | -73.98 Million | -1.38 Billion | -1.85 Billion | -898.62 Million |
Acquisitions | - | 14.53 Million | 11.51 Million | 139.36 Million | 12.89 Million | 99.79 Million |
Investment purchases | - | - | - | - | - | -380.99 Million |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 264.18 Million | 66.66 Million | -2.05 Billion | 24.86 Million | 142.36 Million |
Financing Cash Flow | - | -1.6 Billion | -2.07 Billion | 4.07 Billion | 1.63 Billion | -83.7 Million |
Debt repayment | - | -244.6 Million | -298.88 Million | -5.03 Million | -1.74 Billion | -1.44 Billion |
Dividends payments | - | - | - | -60.41 Million | -48.29 Million | - |
Common Stock Repurchased | - | - | - | 1.61 Billion | -1.74 Billion | - |
Common Stock Issuance | - | - | - | 2.52 Billion | 8.7 Million | - |
Other Financing Activities | - | -1.35 Billion | -1.77 Billion | 4.13 Million | 5.16 Billion | -83.7 Million |
Accounts receivables | - | 663.55 Thousand | 768.91 Thousand | -4.81 Million | -1.13 Billion | -204.14 Million |
Accounts payables | - | -632.14 Million | 36.09 Million | 582.96 Million | 837.12 Million | 475.02 Million |
Inventory | - | 1.57 Million | 11.54 Million | 20.08 Million | -55.29 Million | - |
Other working capital | - | 669.41 Million | 911.1 Million | -4.89 Billion | -204.82 Million | -99.85 Million |
Cash at beginning of period | 27.33 Million | 28.02 Million | 30.2 Million | 1.25 Billion | 796.81 Million | 466.75 Million |
Cash at end of period | 27.33 Million | 27.33 Million | 28.02 Million | 30.2 Million | 1.24 Billion | 786.16 Million |
Capital Expenditure | - | -127.79 Million | -73.98 Million | -1.38 Billion | -1.85 Billion | -898.62 Million |
Effect of forex changes on cash | - | 691.3 Thousand | 2.16 Million | 1.15 Billion | - | 54.62 Million |
Net cash flow / Change in cash | - | -692 Thousand | -2.17 Million | -1.22 Billion | 445.92 Million | 319.41 Million |
Free Cash Flow | - | 1.32 Billion | 1.99 Billion | -3.31 Billion | -1.22 Billion | 587.11 Million |
Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | - | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | 27.33 Million | - | - |
Cash at end of period | - | - | - | 27.33 Million | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
MME
WOCKPHARMA
603390
HINDCOMPOS
RSMXF
QYBX